La Chandra Bioscience

Ahmedabad, India Founded: 2010 • Age: 16 yrs Minicorn
Delivers tissue culture-based plant solutions for farmers.

About La Chandra Bioscience

La Chandra Bioscience was an Agriculture company based in Ahmedabad (India) founded in 2010 by Chandrabhan Khetdanji Gadhvi and Ranjanben Gadhvi. It delivers tissue culture-based plant solutions for farmers. It operates on a B2B model. La Chandra Bioscience has raised $946.67 thousand across 1 funding round from investors including Corona Remedies. The company has 59 employees. La Chandra Bioscience was last valued at $9.02 million in August 2020. Its Indian entity La Chandra Pharmalab Private Limited reported revenue of ₹67.31 Cr. The company is recorded as dissolved. Its focus areas include Biotechnology, Plant Propagation and Tissue Culture. Its competitors include Rootility, ChiBotani, Sun AgriGenetics, Genewin Biotech and Hybrid Agri Biotech and 4 more; 3 of its 9 listed competitors have raised funding.

Company details

La Chandra Bioscience, based in Ahmedabad, focuses on engaging in agricultural activities, advancing biotech innovations, plant propagation, and tissue culture. Delivers tissue culture-based plant solutions for farmers. The company prioritizes operational excellence, innovation, and customer-centric approaches for success. It continues to evolve, meeting industry challenges with strategic approaches.

  • Headquarters Ahmedabad, India
  • Employees 59
  • Founders Chandrabhan Khetdanji Gadhvi, Ranjanben Gadhvi
  • Stage Minicorn
  • Sectors
    Agriculture
  • Website lachandra.com
  • Legal Name La Chandra Pharmalab Private Limited
  • Date of Incorporation 26 Dec, 2013
  • Jurisdiction Ahmedabad, Gujarat, India
Key Metrics
  • Annual Revenue
    ₹67.31 Cr

    FY 2025 · +40% YoY

  • Net Profit
    ₹1.25 Cr

    FY 2025 · 2% margin

  • EBITDA
    ₹6.87 Cr

    FY 2025 · 10% margin

  • Total Equity Funding
    $946.67K (USD)

    in 1 rounds

  • Latest Funding Round
    $946.67K (USD), Seed

    Aug 2020

  • Investors
  • Employee Count
    59

Funding Insights of La Chandra Bioscience

La Chandra Bioscience has successfully raised a total of $946.67K through 1 strategic funding round. The most recent funding activity was a Seed round of $946.67 thousand completed in August 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $946,673
  • Total Rounds 1
  • Last Round Seed — $946,673
  • First Round $946,673

    (Aug 2020)

  • Investors Count 1

All 1 funding rounds of La Chandra Bioscience with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Aug 2020$946,673Seed$9.02MCorona Remedies
–
Valuation history
DateValuationStage
Aug 2020$9.02M••••••••

Last known valuation $9.02M (Aug 2020). 1 investors in total: 1 institutional.

Investors in La Chandra Bioscience

La Chandra Bioscience has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Corona Remedies.

All
Institutional
InvestorDescriptionFounded YearDomainLocation
Manufacturer of pharmaceutical products focused on women's health, cardio-diabetology, pain management, and urology
2004coronaremedies.comAhmedabad, India
Premium access

Investor details for La Chandra Bioscience

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Board of directors of La Chandra Pharmalab Private Limited (La Chandra Bioscience)

La Chandra Pharmalab Private Limited is the primary company behind La Chandra Bioscience. The board of La Chandra Pharmalab Private Limited currently have 3 directors; the longest-serving is Priyvrat Chandrabhan Gadhvi, appointed in 2013. 3 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Priyvrat Chandrabhan Gadhvi
DIN 02437788
Director26 Dec 201312 yrs 9 moLa Chandra Pharmalab Private Limited
Vratika Priyvrat Gadhvi
DIN 03440544
Director26 Feb 201511 yrs 7 moLa Chandra Pharmalab Private Limited
Chandrabhan Khetdanji Gadhvi
DIN 01480242
Director27 Mar 20188 yrs 6 moLa Chandra Pharmalab Private Limited

People of La Chandra Bioscience

2 people are tracked at La Chandra Bioscience (2 in leadership); the tracked headcount is 59.

NameRoleGroup
Co-Founder, DirectorLeadership
Ranjanben Gadhvi
Co-Founder, DirectorLeadership
Premium access

Complete people profiles for La Chandra Bioscience

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Financials of La Chandra Bioscience

Figures of La Chandra Pharmalab Private Limited, the primary company behind La Chandra Bioscience, for FY 2025. Revenue was ₹67.31 Cr (+40% year on year). Net profit was ₹1.25 Cr (2% margin). EBITDA was ₹6.87 Cr (10% margin). Revenue has grown at a compounded annual rate of +18% over three years and +14% over five years.

  • ₹67.31 CrRevenue · FY 2025 · +40% YoY
  • ₹1.25 CrNet profit · 2% margin
  • ₹6.87 CrEBITDA · 10% margin
  • ₹66.4 LakhPaid-up capital
  • 59Employees (provident fund records)
  • +18%Revenue CAGR, 3 years
  • +14%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of La Chandra Pharmalab Private Limited are on its company page.

Premium access

Detailed financial statements for La Chandra Bioscience

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Timeline of La Chandra Bioscience

3 dated milestones of La Chandra Bioscience across 10 years, from founding to its latest funding, stage changes and deals.

  1. Founded La Chandra Bioscience is founded.
  2. Funding First funding round of $947K.
  3. Milestone Reaches Minicorn status.

Competitors of La Chandra Bioscience

La Chandra Bioscience has 9 listed competitors in our database, 3 of them funded. They include Rootility, ChiBotani, Sun AgriGenetics, Genewin Biotech and Hybrid Agri Biotech, among others.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
rootility.com2006Ashkelon, Israel$15M–
Non-GMO seeds are provided through a breeding technology platform.
chibotanic.com2017San Francisco, United States$250,000–
Company generating plant cell cultures for scaling into larger production systems
sunagri.in1999Vadodara, India–146
Developer of plant tissue culture products
genewinbiotech.com2007Hosur, India––
Produces tissue culture plants like bamboo and banana for export and agriculture.
hybridagri.com2008Navi Mumbai, India–12
Plant tissue culture products are produced for farmers.
ficusbiotech.com.np2013Kathmandu, Nepal––
Manufacturer of organic Paulowia, Bamboo plant using tissue culture technology
thomasbiotech.com2019Bengaluru, India––
Developer of technology for tissue culture-mediated rapid clonal multiplication
agropratyaksha.com2014Silchar, India$275,7195
Fruits, vegetables, flowers, and herbs are produced via tissue culture.
abcagrobiotech.com2011Kheda, India––
Delivers comprehensive tissue culture solutions for plants.
Premium access

Detailed competitors of La Chandra Bioscience

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Top companies in Crop Farming & Production

10 companies that operate in the same segment as La Chandra Bioscience (Crop Farming & Production), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Distributor of cannabis products
2011Phoenix, Arizona, United StatesUSD 21.48 MUSD 99.22 M641
Grain trading, processing, and consumer products are handled vertically integrated.
1905Stockholm, Sweden–––
Agricultural commodities are linked from producers to global consumers.
1911Regina, Saskatchewan, CanadaUSD 413 M––
Cane sugar and related products are refined and marketed globally.
1998West Palm Beach, Florida, United States––32
Cultivator and processor of palm oil & rubber
1985London, England, United Kingdom–USD 475.33 M–
Cannabis seeds, concentrates, and oils are produced and supplied.
2005Medford, Oregon, United StatesUSD 750 KUSD 33.09 M–
Diverse products in FMCG, hotels, packaging, and agri-business are offered.
1910Kolkata, West Bengal, India–USD 8.78 B47,360
Provider of agricultural equipment and engineering solutions
1996Winnipeg, Manitoba, CanadaUSD 50 MUSD 1.04 B–
Cooperative organization for milk production, animal health, and dairy services in India.
1946Anand, Gujarat, India–USD 44.2 M571
Agrochemicals and seeds are manufactured and supplied globally.
1956Laverton, Western Australia, Australia–USD 2.27 B3,160
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • ✓
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • ✓
    Full access to every database India & global coverage, advanced filters and rich profile details
  • ✓
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about La Chandra Bioscience

Premium access

Complete news archive for La Chandra Bioscience

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about La Chandra Bioscience

La Chandra Bioscience was founded in 2010 and raised its 1st funding round 10 years after it was founded.

La Chandra Bioscience is headquartered in Ahmedabad, India. It is registered at Ahmedabad, Gujarat, India.

La Chandra Bioscience is a funded company, having raised a total of $946.67K across 1 funding round to date. The company's 1st funding round was a Seed of $946.67K, raised on Aug 2020.

La Chandra Bioscience has 59 employees.

The primary company behind La Chandra Bioscience, La Chandra Pharmalab Private Limited, reported revenue of ₹67.31 Cr for FY 2025, up 40% year on year.

La Chandra Bioscience, based in Ahmedabad, focuses on engaging in agricultural activities, advancing biotech innovations, plant propagation, and tissue culture. Delivers tissue culture-based plant solutions for farmers. The company prioritizes operational excellence, innovation, and customer-centric approaches for success. It continues to evolve, meeting industry challenges with strategic approaches.

La Chandra Bioscience's top competitors include Sun AgriGenetics, Rootility and ChiBotani.

La Chandra Bioscience has 1 investor. Key investors include Corona Remedies.

The valuation of La Chandra Bioscience is $9.02M as of Aug 2020.

La Chandra Bioscience operates through La Chandra Pharmalab Private Limited.

The legal entities of La Chandra Bioscience currently have 3 directors, including Priyvrat Chandrabhan Gadhvi, Vratika Priyvrat Gadhvi, Chandrabhan Khetdanji Gadhvi.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available